Luke Stephen Prockter Moore (Luke S P Moore, Luke Moore, Luke Sp Moore)

Scopus Author ID ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 25

Top Venues

JAC-antimicrobial resistance

BMC infectious diseases

Expert review of anti-infective therapy

Antibiotics (Basel, Switzerland)

Chelsea and Westminster Hospital

Imperial College London (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Chelsea and Westminster Hospital Nov 01 2017

United Kingdom

Consultant :: Clinical Infection Department

Imperial College Healthcare NHS Trust Nov 01 2017

United Kingdom

Consultant :: Microbiology

Imperial College London Apr 01 2016

United Kingdom

Honorary Clinical Research Fellow :: Infection and Immunity

Imperial College Healthcare NHS Trust Apr 01 2016 - Nov 01 2017

United Kingdom

Registrar :: Microbiology

Imperial College London Apr 01 2013 - Mar 31 2016

United Kingdom

Clinical Research Fellow :: Infectious Diseases and Immunity

Imperial College Healthcare NHS Trust Aug 01 2008 - Mar 31 2013

United Kingdom

Registrar :: Microbiology

Education History

Imperial College London Apr 01 2013 - Nov 01 2016

United Kingdom

PHD :: Medicine

London School of Hygiene and Tropical Medicine Aug 01 2007 - Jul 31 2012

United Kingdom

MSC

Queen Mary University of London Aug 01 2008 - Jul 31 2010

United Kingdom

MSC :: Microbiology

Publications

Shahid Bukhari, Stephen Hughes, Nabeela Mughal, Luke Stephen Prockter Moore, Gary Davies, Adrian Varghas Zhang, Megan Ng, Zekiye Karagozlu, Marta Boffito
Nirmatrelvir/ritonavir: real world drug-drug interaction management experience. Expert review of anti-infective therapy (2024)
Shahid Bukhari, Stephen Hughes, Nabeela Mughal, Luke Stephen Prockter Moore, Gary Davies, Adrian Vargas Zhang, Megan Ng, Zekiye Karagozlu, Marta Boffito
Nirmatrelvir/ritonavir: real world drug-drug interaction management experience. Expert review of anti-infective therapy (2024)
Ioannis Baltas, Mark Gilchrist, Eirini Koutoumanou, Malick M Gibani, James E Meiring, Akaninyene Otu, David Hettle, Ameeka Thompson, James R Price, Anna Crepet, Abolaji Atomode, Timothy Crocker-Buque, Dimitrios Spinos, Hudson Guyver, Matija Tausan, Donald Somasunderam, Maxwell Thoburn, Cathleen Chan, Helen Umpleby, Bethany Sharp, Callum Chivers, Devan Suresh Vaghela, Ronak J Shah, Jonathan Foster, Amy Hume, Christopher Smith, Ammara Asif, Dimitrios Mermerelis, Mohammad Abbas Reza, Dominic A Haigh, Thomas Lamb, Loucia Karatzia, Alexandra Bramley, Nikhil Kadam, Konstantinos Kavallieros, Veronica Garcia-Arias, Jane Democratis, Claire S Waddington, Luke Stephen Prockter Moore, Alexander M Aiken
Exploring the views of infection consultants in England on a novel delinked funding model for antimicrobials: the SMASH study. JAC-antimicrobial resistance 5 (4) (2023)
Luke Stephen Prockter Moore, Maria Virginia Villegas, Eric Wenzler, Timothy M Rawson, Rita O Oladele, Yohei Doi, Anucha Apisarnthanarak
Rapid Diagnostic Test Value and Implementation in Antimicrobial Stewardship Across Low-to-Middle and High-Income Countries: A Mixed-Methods Review. Infectious diseases and therapy (2023)
Suveer Singh, Martine Nurek, Sonia Mason, Luke Stephen Prockter Moore, Nabeela Mughal, Marcela P Vizcaychipi
WHY STOP? A prospective observational vignette-based study to determine the cognitive-behavioural effects of rapid diagnostic PCR-based point-of-care test results on antibiotic cessation in ICU infections. BMJ open 13 (11) (2023)
Shivani Singh, Luke Stephen Prockter Moore, Nabeela Mughal, Matthew Ho, Darius Armstrong-James, Suveer Singh
Novel inhaled antifungal for pseudomembranous Aspergillus tracheobronchitis complicating connective tissue disease. Thorax (2022)
Stephen Hughes, Katie L Heard, Nabeela Mughal, Luke Stephen Prockter Moore
Optimization of antimicrobial dosing in patients with acute kidney injury: a single-centre observational study. JAC-antimicrobial resistance 4 (4) (2022)
Shivani Singh, Rajiv Ark, Jason Tatlock, Sundhiya Mandalia, Christine Chung, Berge Azadian, Stephen Hughes, Nabeela Mughal, Luke Stephen Prockter Moore, Suveer Singh
Evaluating the long-term impact of an antimicrobial stewardship programme in a Central London mixed medical and surgical intensive care unit. JAC-antimicrobial resistance 4 (5) (2022)
Sarah Denny, Timothy M Rawson, Peter Hart, Giovanni Satta, Ahmed Abdulaal, Stephen Hughes, Mark Gilchrist, Nabeela Mughal, Luke Stephen Prockter Moore
Bacteraemia variation during the COVID-19 pandemic; a multi-centre UK secondary care ecological analysis. BMC infectious diseases 21 (1) (2021)
Stephen Hughes, Nabeela Mughal, Luke Stephen Prockter Moore
Procalcitonin to Guide Antibacterial Prescribing in Patients Hospitalised with COVID-19. Antibiotics (Basel, Switzerland) 10 (9) (2021)
Ahmed Abdulaal, Aatish Patel, Ahmed Al-Hindawi, Esmita Charani, Saleh A Alqahthani, Gary W Davies, Nabeela Mughal, Luke Stephen Prockter Moore
Clinical Utility and Functionality of an Artificial Intelligence-Based App to Predict Mortality in COVID-19: Mixed Methods Analysis. JMIR formative research 5 (7) (2021)
Alex Soriano, Yehuda Carmeli, Ali S Omrani, Luke Stephen Prockter Moore, Margaret Tawadrous, Paurus Irani
Ceftazidime-Avibactam for the Treatment of Serious Gram-Negative Infections with Limited Treatment Options: A Systematic Literature Review. Infectious diseases and therapy 10 (4) (2021)
Alison Burdett, Christofer Toumazou, Rashmita Sahoo, Adam Mujan, Tsz-Kin Hon, Judith Bedzo-Nutakor, Nicola Casali, Maria Karvela, Mohammadreza Sohbati, Graham S Cooke, Gary W Davies, Luke Stephen Prockter Moore
Pooled sputum to optimise the efficiency and utility of rapid, point-of-care molecular SARS-CoV-2 testing. BMC infectious diseases 21 (1) (2021)
Bernard Hernandez, Pau Herrero-Viñas, Timothy Miles Rawson, Luke Stephen Prockter Moore, Alison Helen Holmes, Pantelis Georgiou
Resistance Trend Estimation Using Regression Analysis to Enhance Antimicrobial Surveillance: A Multi-Centre Study in London 2009-2016. Antibiotics (Basel, Switzerland) 10 (10) (2021)
John Asumang, Katie L Heard, Oliver Troise, Sandra Fahmy, Nabeela Mughal, Luke Stephen Prockter Moore, Stephen Hughes
Evaluation of a thrice weekly administration of teicoplanin in the outpatient setting: a retrospective observational multicentre study. JAC-antimicrobial resistance 3 (1) (2021)
Barnaby F Flower, Jonathan C Brown, Bryony Simmons, Maya Moshe, Rebecca Frise, Rebecca Penn, Ruthiran Kugathasan, Claire Petersen, Anna Daunt, Deborah Ashby, Steven Riley, Christina Joanne Atchison, Graham P Taylor, Sutha Satkunarajah, Lenny Naar, Robert Klaber, Anjna Badhan, Carolina Rosadas, Maryam Khan, Natalia Fernandez, Macià Sureda-Vives, Hannah M Cheeseman, Jessica O'Hara, Gianluca Fontana, Scott John Charles Pallett, Michael Rayment, Rachael Jones, Luke Stephen Prockter Moore, Myra O McClure, Peter Cherepanov, Richard Tedder, Hutan Ashrafian, Robin Shattock, Helen Ward, Ara Darzi, Paul Elliot, Wendy S Barclay, Graham S Cooke
Clinical and laboratory evaluation of SARS-CoV-2 lateral flow assays for use in a national COVID-19 seroprevalence survey. Thorax 75 (12) (2020)
Ahmed Abdulaal, Aatish Patel, Esmita Charani, Sarah Denny, Nabeela Mughal, Luke Stephen Prockter Moore
Prognostic Modeling of COVID-19 Using Artificial Intelligence in the United Kingdom: Model Development and Validation. Journal of medical Internet research 22 (8) (2020)
Ahmed Abdulaal, Aatish Patel, Esmita Charani, Sarah Denny, Saleh A Alqahtani, Gary W Davies, Nabeela Mughal, Luke Stephen Prockter Moore
Comparison of deep learning with regression analysis in creating predictive models for SARS-CoV-2 outcomes. BMC medical informatics and decision making 20 (1) (2020)
Timothy M Rawson, Damien Keng Yen Ming, Raheelah Ahmad, Luke Stephen Prockter Moore, Alison H Holmes
Antimicrobial use, drug-resistant infections and COVID-19. Nature reviews. Microbiology 18 (8) (2020)
Aatish Patel, Ahmed Abdulaal, David Ariyanayagam, Kieran Killington, Sarah J Denny, Nabeela Mughal, Stephen Hughes, Nupur Goel, Gary W Davies, Luke Stephen Prockter Moore, Esmita Charani
Investigating the association between ethnicity and health outcomes in SARS-CoV-2 in a London secondary care population. PloS one 15 (10) (2020)
Alireza Abdolrasouli, Malick M Gibani, Theun de Groot, Andrew M Borman, Peter Hoffman, Berge S Azadian, Nabeela Mughal, Luke Stephen Prockter Moore, Elizabeth M Johnson, Jacques F Meis
A pseudo-outbreak of Rhinocladiella similis in a bronchoscopy unit of a tertiary care teaching hospital in London, United Kingdom. Mycoses 64 (4) (2020)
Alice E Lee, Kanchana Niruttan, Timothy M Rawson, Luke Stephen Prockter Moore
Antibacterial resistance in ophthalmic infections: a multi-centre analysis across UK care settings. BMC infectious diseases 19 (1) (2019)
Fatema Juma, Joshua J Cave, Hector Gonzales, Luke Stephen Prockter Moore
Non-typhoidal salmonellosis presenting as acute calculus cholecystitis. BMJ case reports 12 (7) (2019)
Dipender Gill, Beben Benyamin, Luke Stephen Prockter Moore, Grace Monori, Ang Zhou, Fotios Koskeridis, Evangelos Evangelou, Mike Laffan, Ann P Walker, Konstantinos K Tsilidis, Abbas Dehghan, Paul Elliott, Elina Hyppӧnen, Joanna Tzoulaki
Associations of genetically determined iron status across the phenome: A mendelian randomization study. PLoS medicine 16 (6) (2019)
Christianne Micallef, Monsey McLeod, Enrique Castro-Sánchez, Myriam Drysdale, Esmita Charani, Luke Stephen Prockter Moore, Mark Gilchrist, Fran Husson, Céire E Costelloe, Alison Helen Holmes
An Evidence-Based Antimicrobial Stewardship Smartphone App for Hospital Outpatients: Survey-based Needs Assessment Among Patients. JMIR mHealth and uHealth 4 (3) (2016)

Luke Stephen Prockter Moore.css-eqlu8i{font-size:small;padding-left:4px;} (Luke S P Moore, Luke Moore, Luke Sp Moore)

Publication Activity (10 Years)

Top Topics

Top Venues

Luke Stephen Prockter Moore (Luke S P Moore, Luke Moore, Luke Sp Moore)